Publications by Vera Maria Abeler
150 publications found
Original articles
Progesterone Receptor Expression Is an Independent Prognosticator in FIGO Stage I Uterine Leiomyosarcoma
Am J Clin Pathol, 145 (4), 449-58
DOI 10.1093/ajcp/aqw030, PubMed 27149024
Entropy-based adaptive nuclear texture features are independent prognostic markers in a total population of uterine sarcomas
Cytometry A, 87 (4), 315-25
DOI 10.1002/cyto.a.22601, PubMed 25483227
Genomic profile of ovarian carcinomas
BMC Cancer, 14, 315
DOI 10.1186/1471-2407-14-315, PubMed 24886194
Gene expression signatures of primary and metastatic uterine leiomyosarcoma
Hum Pathol, 45 (4), 691-700
DOI 10.1016/j.humpath.2013.11.003, PubMed 24485798
Genomic aberration patterns and expression profiles of squamous cell carcinomas of the vulva
Genes Chromosomes Cancer, 52 (6), 551-63
DOI 10.1002/gcc.22053, PubMed 23404381
Gene expression signatures differentiate uterine endometrial stromal sarcoma from leiomyosarcoma
Gynecol Oncol, 128 (2), 349-55
DOI 10.1016/j.ygyno.2012.11.021, PubMed 23178314
[Young man with severe back pain]
Tidsskr Nor Laegeforen, 132 (14), 1626-9
DOI 10.4045/tidsskr.11.1059, PubMed 22875130
DNA ploidy may be a prognostic marker in stage I and II serous adenocarcinoma of the endometrium
Virchows Arch, 461 (3), 291-8
DOI 10.1007/s00428-012-1275-2, PubMed 22824999
The prognostic value of adaptive nuclear texture features from patient gray level entropy matrices in early stage ovarian cancer
Anal Cell Pathol (Amst), 35 (4), 305-14
DOI 10.3233/ACP-2012-0065, PubMed 22596183
Genomic imbalances in endometrial adenocarcinomas - comparison of DNA ploidy, karyotyping and comparative genomic hybridization
Mol Oncol, 6 (1), 98-107
DOI 10.1016/j.molonc.2011.10.002, PubMed 22062770
Prognostic importance of DNA ploidy and DNA index in stage I and II endometrioid adenocarcinoma of the endometrium
Ann Oncol, 23 (5), 1178-1184
DOI 10.1093/annonc/mdr368, PubMed 21965471
Diagnostic immunohistochemistry in uterine sarcomas: a study of 397 cases
Int J Gynecol Pathol, 30 (3), 236-43
DOI 10.1097/PGP.0b013e318200caff, PubMed 21464730
Robot-assisted laparoscopic radical hysterectomy: comparison with total laparoscopic hysterectomy and abdominal radical hysterectomy; one surgeon's experience at the Norwegian Radium Hospital
Gynecol Oncol, 121 (3), 600-4
DOI 10.1016/j.ygyno.2011.02.002, PubMed 21353294
Array-CGH analysis of microdissected chromosome 19 markers in ovarian carcinoma identifies candidate target genes
Genes Chromosomes Cancer, 49 (11), 1046-53
DOI 10.1002/gcc.20813, PubMed 20725991
DNA ploidy heterogeneity in endometrial carcinoma: comparison between curettage and hysterectomy specimens
Int J Gynecol Pathol, 29 (6), 572-8
DOI 10.1097/PGP.0b013e3181e2e8ee, PubMed 20881853
Genomic aberrations in borderline ovarian tumors
J Transl Med, 8, 21
DOI 10.1186/1479-5876-8-21, PubMed 20184781
Tumor spreading to the contralateral ovary in bilateral ovarian carcinoma is a late event in clonal evolution
J Oncol, 2010, 646340
DOI 10.1155/2010/646340, PubMed 19759843
Beta-catenin expression in uterine sarcomas and its relation to clinicopathological parameters
Eur J Cancer, 45 (13), 2412-7
DOI 10.1016/j.ejca.2009.06.017, PubMed 19622417
Gross genomic alterations differ between serous borderline tumors and serous adenocarcinomas--an image cytometric DNA ploidy analysis of 307 cases with histogenetic implications
Virchows Arch, 454 (6), 677-83
DOI 10.1007/s00428-009-0778-y, PubMed 19421773
The prognostic value of DNA ploidy in a total population of uterine sarcomas
Ann Oncol, 20 (6), 1037-41
DOI 10.1093/annonc/mdn765, PubMed 19201782
Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients
Histopathology, 54 (3), 355-64
DOI 10.1111/j.1365-2559.2009.03231.x, PubMed 19236512
Reverse painting of microdissected chromosome 19 markers in ovarian carcinoma identifies a complex rearrangement map
Genes Chromosomes Cancer, 48 (2), 184-93
DOI 10.1002/gcc.20628, PubMed 18973136
Large scale genomic instability as an additive prognostic marker in early prostate cancer
Cell Oncol, 31 (4), 251-9
DOI 10.3233/CLO-2009-0463, PubMed 19633362
Consistent numerical chromosome aberrations in thecofibromas of the ovary
Virchows Arch, 452 (3), 269-76
DOI 10.1007/s00428-007-0561-x, PubMed 18188592
A distinct pattern in the DNA ploidy histograms of hydatidiform moles and nonmolar abortuses is caused by accumulation of trophoblasts in the late s-phase
Int J Gynecol Pathol, 26 (4), 432-6
DOI 10.1097/pgp.0b013e31803c7c2e, PubMed 17885494
Robotic radical hysterectomy in early-stage cervical carcinoma patients, comparing results with total laparoscopic radical hysterectomy cases. The future is now?
Int J Med Robot, 3 (3), 224-8
DOI 10.1002/rcs.152, PubMed 17924449
Trisomy 7 in postoperative spindle cell nodules
Cancer Genet Cytogenet, 174 (2), 147-50
DOI 10.1016/j.cancergencyto.2006.12.003, PubMed 17452257
Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers
Mol Cancer, 6, 12
DOI 10.1186/1476-4598-6-12, PubMed 17274819
Novel epigenetically deregulated genes in testicular cancer include homeobox genes and SCGB3A1 (HIN-1)
J Pathol, 210 (4), 441-9
DOI 10.1002/path.2064, PubMed 17029216
The activated nerve growth factor receptor p-TrkA is selectively expressed in advanced-stage ovarian carcinoma
Hum Pathol, 38 (1), 140-6
DOI 10.1016/j.humpath.2006.06.027, PubMed 16996570
Image cytometry DNA ploidy correlates with histological subtypes in endometrial carcinomas
Mod Pathol, 19 (9), 1227-35
DOI 10.1038/modpathol.3800641, PubMed 16729014
A new approach to treatment of early-stage cervical carcinoma: entire laparoscopic abdominal radical hysterectomy with bilateral pelvic lymphadenectomy without vaginal cuff closure--case reports
Eur J Gynaecol Oncol, 27 (5), 513-8
PubMed 17139990
Robotic-assisted laparoscopic radical hysterectomy (Piver type III) with pelvic node dissection--case report
Eur J Gynaecol Oncol, 27 (5), 531-3
PubMed 17139995
The AP-2gamma transcription factor is upregulated in advanced-stage ovarian carcinoma
Gynecol Oncol, 100 (3), 462-8
DOI 10.1016/j.ygyno.2005.09.022, PubMed 16216317
CD10, estrogen and progesterone receptor expression in ovarian adenosarcoma
Gynecol Oncol, 99 (2), 493-6
DOI 10.1016/j.ygyno.2005.06.013, PubMed 16051333
Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development
Cancer Res, 65 (13), 5588-98
DOI 10.1158/0008-5472.CAN-05-0153, PubMed 15994931
beta-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: a study in 253 patients
Eur J Cancer, 41 (8), 1127-34
DOI 10.1016/j.ejca.2005.01.022, PubMed 15911235
The loss of NKX3.1 expression in testicular--and prostate--cancers is not caused by promoter hypermethylation
Mol Cancer, 4 (1), 8
DOI 10.1186/1476-4598-4-8, PubMed 15691383
Evaluation of genomic changes in a large series of malignant ovarian germ cell tumors--relation to clinicopathologic variables
Cancer Genet Cytogenet, 155 (1), 25-32
DOI 10.1016/j.cancergencyto.2004.02.010, PubMed 15527899
Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma
Hum Mutat, 24 (1), 21-34
DOI 10.1002/humu.20055, PubMed 15221786
Genomic aberrations in carcinomas of the uterine corpus
Genes Chromosomes Cancer, 40 (3), 229-46
DOI 10.1002/gcc.20038, PubMed 15139002
Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma
Gynecol Oncol, 93 (3), 680-5
DOI 10.1016/j.ygyno.2004.03.021, PubMed 15196864
Joint effects of different human papillomaviruses and Chlamydia trachomatis infections on risk of squamous cell carcinoma of the cervix uteri
Eur J Cancer, 40 (7), 1058-65
DOI 10.1016/j.ejca.2003.11.032, PubMed 15093583
TP53 mutations in early-stage ovarian carcinoma, relation to long-term survival
Br J Cancer, 90 (3), 678-85
DOI 10.1038/sj.bjc.6601537, PubMed 14760384
Immunohistochemical expression of CD10 antigen in uterine adenosarcoma
Int J Gynecol Cancer, 14 (6), 1118-21
DOI 10.1111/j.1048-891X.2004.14610.x, PubMed 15571618
NKX3.1 expression is lost in testicular germ cell tumors
Am J Pathol, 163 (6), 2149-54
DOI 10.1016/S0002-9440(10)63571-7, PubMed 14633588
The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1, and p16INK4/MTS1 in adenocarcinomas of the uterine cervix: an immunohistochemical evaluation of expression patterns in population-based material from 142 patients with international federation of gynecology and obstetrics stage I and II adenocarcinoma
Cancer, 98 (9), 1880-9
DOI 10.1002/cncr.11727, PubMed 14584070
Cytogenetic characterization of tumors of the vulva and vagina
Genes Chromosomes Cancer, 38 (2), 137-48
DOI 10.1002/gcc.10263, PubMed 12939741
Large-scale genomic instability predicts long-term outcome for women with invasive stage I ovarian cancer
Ann Oncol, 14 (10), 1494-500
DOI 10.1093/annonc/mdg403, PubMed 14504048
Genome profiles of bilateral dysgerminomas, a unilateral gonadoblastoma, and a metastasis from a 46, XY phenotypic female
Hum Pathol, 34 (9), 946-9
DOI 10.1016/s0046-8177(03)00345-9, PubMed 14562293
Reproducibility of classification in non-squamous cell carcinomas of the uterine cervix
Gynecol Oncol, 90 (2), 282-9
DOI 10.1016/s0090-8258(03)00280-4, PubMed 12893188
Candidate genes for testicular cancer evaluated by in situ protein expression analyses on tissue microarrays
Neoplasia, 5 (5), 397-404
DOI 10.1016/s1476-5586(03)80042-8, PubMed 14670177
Gestational trophoblastic tumors in Norway, 1968-1997: patient characteristics, treatment, and prognosis
Gynecol Oncol, 87 (1), 71-6
DOI 10.1006/gyno.2002.6801, PubMed 12468345
A prospective study of the relationship between prediagnostic human papillomavirus seropositivity and HPV DNA in subsequent cervical carcinomas
Br J Cancer, 87 (2), 175-80
DOI 10.1038/sj.bjc.6600454, PubMed 12107839
Dissociated expression of Bcl-2 and Ki-67 in endometrial lesions: diagnostic and histogenetic implications
Int J Gynecol Pathol, 21 (2), 155-60
DOI 10.1097/00004347-200204000-00008, PubMed 11917225
Placental site trophoblastic tumor (PSTT) in mother and child: first report of PSTT in infancy
Med Pediatr Oncol, 38 (3), 187-91; discussion 192
DOI 10.1002/mpo.1308, PubMed 11836719
Histologic subtype has minor importance for overall survival in patients with adenocarcinoma of the uterine cervix: a population-based study of prognostic factors in 505 patients with nonsquamous cell carcinomas of the cervix
Cancer, 92 (9), 2471-83
DOI 10.1002/1097-0142(20011101)92:9<2471::aid-cncr1597>3.0.co;2-k, PubMed 11745305
Clear-cell and papillary serous cancer: treatment options
Best Pract Res Clin Obstet Gynaecol, 15 (3), 433-46
DOI 10.1053/beog.2000.0187, PubMed 11476564
Fibroblast growth factor receptor 3 (FGFR3) - analyses of the S249C mutation and protein expression in primary cervical carcinomas
Anal Cell Pathol, 23 (2), 45-9
DOI 10.1155/2001/521873, PubMed 11904459
Carcinoma of the fallopian tube
Cancer, 89 (10), 2076-84
PubMed 11066048
Primary cervical carcinomas show 2 common regions of deletion at 3P, 1 within the FHIT gene: evaluation of allelic imbalance at FHIT, RB1 and TP53 in relation to survival
Int J Cancer, 88 (2), 217-22
DOI 10.1002/1097-0215(20001015)88:2<217::aid-ijc11>3.0.co;2-i, PubMed 11004671
Histopathologic subtyping of cervical adenocarcinoma reveals increasing incidence rates of endometrioid tumors in all age groups: a population based study with review of all nonsquamous cervical carcinomas in Norway from 1966 to 1970, 1976 to 1980, and 1986 to 1990
Cancer, 89 (6), 1291-9
DOI 10.1002/1097-0142(20000915)89:6<1291::AID-CNCR14>3.3.CO;2-F, PubMed 11002225
[Telepathology at the Norwegian Radium Hospital]
Tidsskr Nor Laegeforen, 120 (18), 2170-3
PubMed 11006741
DNA copy number changes in malignant ovarian germ cell tumors
Cancer Res, 60 (11), 3025-30
PubMed 10850452
Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument
Ann Oncol, 11 (3), 281-8
DOI 10.1023/a:1008399414923, PubMed 10811493
[Early stage ovarian carcinoma--diagnosis and treatment]
Tidsskr Nor Laegeforen, 120 (4), 476-8
PubMed 10833940
[DNA ploidy in epithelial ovarian cancer--an independent prognostic factor]
Tidsskr Nor Laegeforen, 120 (1), 43-9
PubMed 10815478
A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens
Am J Surg Pathol, 23 (9), 1102-8
DOI 10.1097/00000478-199909000-00014, PubMed 10478671
Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma
Gynecol Oncol, 74 (2), 245-51
DOI 10.1006/gyno.1999.5420, PubMed 10419739
Karyotypic findings in tumors of the vulva and vagina
Cancer Genet Cytogenet, 111 (1), 87-91
DOI 10.1016/s0165-4608(98)00226-x, PubMed 10326597
The invasive front of carcinomas. The most important area for tumour prognosis?
Anticancer Res, 18 (6B), 4757-64
PubMed 9891553
TP53 protein accumulation and gene mutation in relation to overexpression of MDM2 protein in ovarian borderline tumours and stage I carcinomas
J Pathol, 181 (2), 158-65
DOI 10.1002/(SICI)1096-9896(199702)181:2<158::AID-PATH742>3.0.CO;2-8, PubMed 9120719
The problem of skipped generation and subclinical disease in familial breast-ovarian cancer
Acta Obstet Gynecol Scand, 76 (2), 166-8
DOI 10.3109/00016349709050074, PubMed 9049291
Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern
Cancer, 78 (8), 1740-7
DOI 10.1002/(sici)1097-0142(19961015)78:8<1740::aid-cncr14>3.0.co;2-y, PubMed 8859187
Early detection of familial ovarian cancer
Eur J Cancer, 32A (10), 1645-51
DOI 10.1016/0959-8049(96)00137-2, PubMed 8983269
Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma. An immunohistochemical study
Cancer, 78 (3), 433-40
DOI 10.1002/(SICI)1097-0142(19960801)78:3<433::AID-CNCR9>3.0.CO;2-K, PubMed 8697388
Human papilloma virus has no prognostic significance in cervical carcinoma
Eur J Cancer, 32A (8), 1349-53
DOI 10.1016/0959-8049(96)00089-5, PubMed 8869098
Evaluation of the prognostic significance of nm23/NDP kinase protein expression in cervical carcinoma: an immunohistochemical study
Gynecol Oncol, 61 (3), 378-83
DOI 10.1006/gyno.1996.0160, PubMed 8641619
Malignant melanoma of the vulva FIGO stage I: Evaluation of prognostic factors in 43 patients with emphasis on DNA ploidy and surgical treatment
Gynecol Oncol, 61 (2), 253-8
DOI 10.1006/gyno.1996.0135, PubMed 8626143
State of art in endometrial carcinoma
4TH CONGRESS OF THE EUROPEAN SOCIETY FOR GYNAECOLOGICAL ENDOSCOPY: THE UTERUS THROUGHOUT THE WOMAN'S LIFE, 107-115
No prognostic impact of flow-cytometric measured DNA ploidy and S-phase fraction in cancer of the uterine cervix: a prospective study of 465 patients
Gynecol Oncol, 57 (1), 79-85
DOI 10.1006/gyno.1995.1102, PubMed 7705705
Influence of HSP27 and steroid receptor status on provera sensitivity, DNA-ploidy and survival of females with endometrial cancer
Int J Gynecol Cancer, 5 (2), 94-100
DOI 10.1046/j.1525-1438.1995.05020094.x, PubMed 11578461
Malignant melanoma of the vulva. Evaluation of prognostic factors with emphasis on DNA ploidy in 75 patients
Cancer, 75 (1), 72-80
DOI 10.1002/1097-0142(19950101)75:1<72::aid-cncr2820750113>3.0.co;2-g, PubMed 7804980
Rates of regression and progression of dysplastic lesions in the nasal mucosa in nickel workers: a Markov model approach
Sci Total Environ, 148 (2-3), 311-8
DOI 10.1016/0048-9697(94)90409-x, PubMed 8029708
Small cell carcinoma of the cervix. A clinicopathologic study of 26 patients
Cancer, 73 (3), 672-7
DOI 10.1002/1097-0142(19940201)73:3<672::aid-cncr2820730328>3.0.co;2-r, PubMed 8299089
Human papillomavirus infection in Norwegian women with cervical cancer
APMIS, 102 (2), 122-8
DOI 10.1111/j.1699-0463.1994.tb04856.x, PubMed 8167008
DNA ploidy; the most important prognostic factor in patients with borderline tumors of the ovary
Int J Gynecol Cancer, 3 (6), 349-358
DOI 10.1046/j.1525-1438.1993.03060349.x, PubMed 11578368
Are borderline tumors of the ovary overtreated both surgically and systemically? A review of four prospective randomized trials including 253 patients with borderline tumors
Gynecol Oncol, 51 (2), 236-43
DOI 10.1006/gyno.1993.1279, PubMed 8276300
[Villous glandular adenocarcinoma of the uterine cervix. A subtype with favourable prognosis?]
Tidsskr Nor Laegeforen, 113 (20), 2569-71
PubMed 8236177
Analysis of prognostic factors in stage I epithelial ovarian carcinoma: importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapse
Am J Obstet Gynecol, 169 (1), 40-52
DOI 10.1016/0002-9378(93)90129-7, PubMed 8333474
Overexpression of p53 protein and c-erbB-2 protein in small cell carcinoma of the cervix uteri
Zentralbl Pathol, 139 (2), 153-6
PubMed 8103676
A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982. A review of clinicopathologic features and treatment modalities
Cancer, 71 (5), 1810-20
DOI 10.1002/1097-0142(19930301)71:5<1810::aid-cncr2820710516>3.0.co;2-v, PubMed 8383580
Clinical stage I carcinoma of the cervix. Value of MR imaging in determining invasion into the parametrium
Acta Radiol, 34 (2), 130-2
PubMed 8452717
HOW OFTEN IS DYSPLASIA DIAGNOSED BY BIOPSY OR SMEAR EXAMINATION - APPLICATION OF A MAXIMUM-LIKELIHOOD BASED METHOD TO THE ASSESSMENT OF DETECTION RATES IN THE NASAL-MUCOSA OF NICKEL WORKERS
Anal. Cell. Pathol., 4 (6), 451-459
How often is dysplasia diagnosed by biopsy or smear examination? Application of a maximum likelihood based method to the assessment of detection rates in the nasal mucosa of nickel workers
Anal Cell Pathol, 4 (6), 451-9
PubMed 1457387
Prognostic value of pre- and postoperative serum CA 125 levels in ovarian cancer: new aspects and multivariate analysis
Obstet Gynecol, 79 (6), 1002-10
PubMed 1579296
Randomized trial comparing cisplatin with radioactive phosphorus or whole-abdomen irradiation as adjuvant treatment of ovarian cancer
Cancer, 69 (3), 741-9
DOI 10.1002/1097-0142(19920201)69:3<741::aid-cncr2820690322>3.0.co;2-g, PubMed 1730124
Endometrial adenocarcinoma with squamous cell differentiation
Cancer, 69 (2), 488-95
DOI 10.1002/1097-0142(19920115)69:2<488::aid-cncr2820690236>3.0.co;2-o, PubMed 1728379
CA125 and placental alkaline phosphatase as serum tumor markers in epithelial ovarian carcinoma
Tumour Biol, 13 (3), 168-74
DOI 10.1159/000217761, PubMed 1626181
Multispectral analysis of uterine corpus tumors in magnetic resonance imaging
Magn Reson Med, 23 (1), 55-76
DOI 10.1002/mrm.1910230108, PubMed 1734184
Carcinoma of the endometrium in Norway: a histopathological and prognostic survey of a total population
Int J Gynecol Cancer, 2 (1), 9-22
DOI 10.1046/j.1525-1438.1992.02010009.x, PubMed 11576230
Cancer of the endometrium: value of MR imaging in determining depth of invasion into the myometrium
AJR Am J Roentgenol, 157 (6), 1221-3
DOI 10.2214/ajr.157.6.1950869, PubMed 1950869
Undifferentiated carcinoma of the endometrium. A histopathologic and clinical study of 31 cases
Cancer, 68 (1), 98-105
DOI 10.1002/1097-0142(19910701)68:1<98::aid-cncr2820680120>3.0.co;2-r, PubMed 2049761
Endometrial adenocarcinoma in Norway. A study of a total population
Cancer, 67 (12), 3093-103
DOI 10.1002/1097-0142(19910615)67:12<3093::aid-cncr2820671226>3.0.co;2-l, PubMed 2044053
Clinical stage I carcinoma of the cervix: value of MR imaging in determining degree of invasiveness
AJR Am J Roentgenol, 156 (6), 1191-4
DOI 10.2214/ajr.156.6.2028866, PubMed 2028866
The prevalence of human papillomavirus type 16 and 18 DNA in cervical cancer in different age groups: a study on the incidental cases of cervical cancer in Norway in 1983
Gynecol Oncol, 41 (2), 141-8
DOI 10.1016/0090-8258(91)90274-9, PubMed 1646757
Clear cell carcinoma of the endometrium: a histopathological and clinical study of 97 cases
Gynecol Oncol, 40 (3), 207-17
DOI 10.1016/0090-8258(90)90279-t, PubMed 2013441
PROGNOSTIC FACTORS IN THE TREATMENT OF STAGE-1B ADENOCARCINOMA OF THE CERVIX
Int. J. Gynecol. Cancer, 1 (2), 69-74
DOI 10.1111/j.1525-1438.1991.tb00018.x
Serous papillary carcinoma of the endometrium: a histopathological study of 22 cases
Gynecol Oncol, 39 (3), 266-71
DOI 10.1016/0090-8258(90)90250-o, PubMed 2258069
[A phase II study of 5-fluorouracil/cisplatin in recurrent cervical cancer]
Tidsskr Nor Laegeforen, 110 (21), 2759-62
PubMed 2219049
Management of malignant ovarian immature teratoma. Role of adriamycin
Cancer, 66 (5), 882-6
DOI 10.1002/1097-0142(19900901)66:5<882::aid-cncr2820660512>3.0.co;2-8, PubMed 2201432
Cellular DNA content as a new prognostic tool in patients with borderline tumors of the ovary
Gynecol Oncol, 38 (3), 452-7
DOI 10.1016/0090-8258(90)90090-8, PubMed 2172121
Nasal mucosa in workers exposed to formaldehyde: a pilot study
Br J Ind Med, 47 (2), 116-21
DOI 10.1136/oem.47.2.116, PubMed 2310715
A phase II study of 5-fluorouracil/cisplatinum in recurrent cervical cancer
Acta Oncol, 29 (1), 25-8
DOI 10.3109/02841869009089987, PubMed 2310600
A randomized trial of adjuvant progestagen in early endometrial cancer
Cancer, 64 (5), 1011-6
DOI 10.1002/1097-0142(19890901)64:5<1011::aid-cncr2820640507>3.0.co;2-7, PubMed 2667746
[Clear cell adenocarcinoma of the cervix uteri and vagina in young women in Norway]
Tidsskr Nor Laegeforen, 109 (15), 1634-7
PubMed 2741143
[Intestinal spirochaetosis]
Tidsskr Nor Laegeforen, 109 (6), 698-9
PubMed 2922737
Colony-forming ability of human ovarian carcinomas in the Courtenay soft agar assay
Anticancer Res, 9 (6), 1577-82
PubMed 2483300
Observer variation in histologic classification of malignant and borderline ovarian tumors
Hum Pathol, 19 (9), 1030-5
DOI 10.1016/s0046-8177(88)80082-0, PubMed 3417288
Primary adenocarcinoma localized to the fallopian tubes: report on 33 cases
Gynecol Oncol, 30 (2), 183-6
DOI 10.1016/0090-8258(88)90022-4, PubMed 3371742
Small cell carcinoma of the ovary. A report of six cases
Int J Gynecol Pathol, 7 (4), 315-29
DOI 10.1097/00004347-198812000-00003, PubMed 2852647
Evaluation of serum CA 125 levels in the monitoring of ovarian cancer
Am J Obstet Gynecol, 157 (1), 88-92
DOI 10.1016/s0002-9378(87)80352-6, PubMed 2440307
Development of brush cytology for detection of metaplastic and dysplastic nasal mucosa lesions. A preliminary report
Acta Otolaryngol, 101 (3-4), 299-305
DOI 10.3109/00016488609132842, PubMed 3705955
Sarcoid reaction of hilar and paratracheal lymph nodes in patients treated for testicular cancer
Cancer, 56 (9), 2212-6
DOI 10.1002/1097-0142(19851101)56:9<2212::aid-cncr2820560913>3.0.co;2-n, PubMed 4052967
Prevalence of antibodies to herpes simplex virus and frequency of HLA antigens in patients with preinvasive and invasive cervical cancer
Gynecol Oncol, 18 (3), 349-58
DOI 10.1016/0090-8258(84)90047-7, PubMed 6086470
Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients
Gynecol Oncol, 17 (1), 85-103
DOI 10.1016/0090-8258(84)90063-5, PubMed 6693055
Multi-modality treatment in males with advanced malignant germ cell tumours. II. Experience with surgery and radiotherapy following cis-platinum-based chemotherapy
Scand J Urol Nephrol, 18 (1), 21-6
DOI 10.3109/00365598409182159, PubMed 6326253
Clinical (stage III) as compared to subclinical intrapelvic extrauterine tumor spread in endometrial carcinoma: a clinical and histopathological study of 175 patients
Gynecol Oncol, 17 (1), 64-74
DOI 10.1016/0090-8258(84)90061-1, PubMed 6693053
Stage IV endometrial carcinoma: a clinical and histopathological study of 83 patients
Gynecol Oncol, 17 (1), 75-84
DOI 10.1016/0090-8258(84)90062-3, PubMed 6693054
Multi-modality treatment of advanced malignant germ cell tumours in males. I. Experience with cis-platinum-based combination chemotherapy
Scand J Urol Nephrol, 18 (1), 13-9
DOI 10.3109/00365598409182158, PubMed 6201998
Endometrial carcinoma with cervical involvement (stage II): prognostic factors and value of combined radiological-surgical treatment
Gynecol Oncol, 13 (1), 76-86
DOI 10.1016/0090-8258(82)90011-7, PubMed 7060995
Squamous cell carcinoma in situ of the vulva. A clinical and histopathological study
Gynecol Oncol, 11 (2), 224-9
DOI 10.1016/s0090-8258(81)80013-3, PubMed 7215958
Individualized treatment of stage I carcinoma of the vulva
Obstet Gynecol, 57 (1), 85-9
PubMed 7454180
Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients
Obstet Gynecol, 56 (4), 419-27
PubMed 6999399
Factors influencing the treatment of patients with stage Ia carcinoma of the cervix
Br J Obstet Gynaecol, 86 (8), 593-7
DOI 10.1111/j.1471-0528.1979.tb10819.x, PubMed 497128
Sarcoidosis of the cardiac conducting system
Am Heart J, 97 (6), 701-7
DOI 10.1016/0002-8703(79)90004-8, PubMed 433747
Review articles
Molecular characteristics of malignant ovarian germ cell tumors and comparison with testicular counterparts: implications for pathogenesis
Endocr Rev, 34 (3), 339-76
DOI 10.1210/er.2012-1045, PubMed 23575763
Diagnosis and treatment of sarcoma of the uterus. A review
Acta Oncol, 51 (6), 694-705
DOI 10.3109/0284186X.2012.689111, PubMed 22793037
Diagnosis and treatment of borderline ovarian neoplasms "the state of the art"
Eur J Gynaecol Oncol, 30 (5), 471-82
PubMed 19899396
Primary ovarian angiosarcoma presenting as malignant cells in ascites: case report and review of the literature
Diagn Cytopathol, 32 (5), 307-9
DOI 10.1002/dc.20245, PubMed 15830366
[Surgery and sentinel node examination in early vulvar cancer]
Tidsskr Nor Laegeforen, 121 (23), 2723-7
PubMed 11699381
[Borderline tumors of the ovary]
Tidsskr Nor Laegeforen, 120 (23), 2764-70
PubMed 11107921
[Endometrial hyperplasia--diagnosis and treatment]
Tidsskr Nor Laegeforen, 119 (14), 2030-4
PubMed 10394278
Endometrial squamous cell carcinoma: report of three cases and review of the literature
Gynecol Oncol, 36 (3), 321-6
DOI 10.1016/0090-8258(90)90134-7, PubMed 2180795
Other articles
Endometrioid neoplasia retrogressive terminology - Reply
Am. J. Surg. Pathol., 24 (5), 754-755
DOI 10.1097/00000478-200005000-00021
Human germ cell tumours: expression of gamma-glutamyl transpeptidase and sensitivity to cisplatin
Br J Cancer, 81 (1), 75-9
DOI 10.1038/sj.bjc.6690653, PubMed 10487615
[Telepathology in Norway]
Tidsskr Nor Laegeforen, 119 (9), 1335
PubMed 10327860
Alveolar soft-part sarcoma in the uterine cervix
Arch Pathol Lab Med, 113 (10), 1179-83
PubMed 2802951
Granulocytic sarcoma (chloroma) of the uterine cervix: report of two cases
Int J Gynecol Pathol, 2 (1), 88-92
DOI 10.1097/00004347-198301000-00008, PubMed 6192105
Theses
Endometrial carcinoma in Norway: morphology and prognosis
The Norwegian Cancer Society, [Oslo], 1 b. (flere pag.)
BIBSYS 91096209x, ISBN 82-90187-76-9